Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
myo-inositol + NAD+ = 2,4,6/3,5-pentahydroxycyclohexanone + NADH + H+
ordered sequential Bi-Bi mechanism in the absence of products, residues Y233, Y235, H176, and D172 are important for activity
myo-inositol + NAD+ = 2,4,6/3,5-pentahydroxycyclohexanone + NADH + H+
myo-inositol + NAD+ = 2,4,6/3,5-pentahydroxycyclohexanone + NADH + H+
His176 and Asp172 are proposed to act as the catalytic dyad, in which His176 is proposed to be the acid/base catalyst
-
myo-inositol + NAD+ = 2,4,6/3,5-pentahydroxycyclohexanone + NADH + H+
Lys97, Asp172, and His176 are the catalytic triad involved in the catalytic mechanism, overview
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(1S,2S,3R,4S,5S)-5-(allyloxy)cyclohexane-1,2,3,4-tetrol + NAD+
?
-
-
-
?
(1S,2S,3R,4S,5S)-5-(benzyloxy)cyclohexane-1,2,3,4-tetrol + NAD+
?
-
-
-
?
(1S,2S,3R,4S,5S)-5-methoxycyclohexane-1,2,3,4-tetrol + NAD+
?
-
-
-
?
4-([[(1S,2S,3R,4S,5S)-2,3,4,5-tetrahydroxycyclohexyl]oxy]methyl)benzoic acid + NAD+
?
-
-
-
?
4-methylbenzenesulfonyl-myo-inositol + NAD+
? + NADH + H+
-
-
-
?
4-O-((1S)-10-camphor-sulfonyl)-myo-inositol + NAD+
? + NADH + H+
-
-
-
?
4-O-((4-methyloxycarbonyl)-benzyl)-myo-inositol + NAD+
? + NADH + H+
-
-
-
?
4-O-(4-carboxybenzyl)-myo-inositol + NAD+
? + NADH + H+
-
-
-
?
4-O-(trans-cinnamoyl)-myo-inositol + NAD+
? + NADH + H+
-
-
-
?
4-O-allyl-myo-inositol + NAD+
? + NADH + H+
-
-
-
?
4-O-alpha-D-glucopyranosyl-myo-inositol + NAD+
? + NADH + H+
-
-
-
?
4-O-benzyl-myo-inositol + NAD+
? + NADH + H+
-
-
-
?
4-O-methyl-myo-inositol + NAD+
? + NADH + H+
-
-
-
?
4-O-[(2-methylphenyl)methyl]-myo-inositol + NAD+
? + NADH + H+
-
-
-
?
4-O-[(3-methylphenyl)methyl]-myo-inositol + NAD+
? + NADH + H+
-
-
-
?
D-glucose + NAD+
D-gluconate + NADH
9% of the activity compared to myo-inositol as substrate
-
?
D-xylose + NAD+
? + NADH
7% of the activity compared to myo-inositol as substrate
-
?
melibiose + NAD+
?
-
-
-
?
methyl 4-([[(1S,2S,3R,4S,5S)-2,3,4,5-tetrahydroxycyclohexyl]oxy]methyl)benzoate + NAD+
?
-
-
-
?
myo-inositol + NAD+
2,4,6/3,5-pentahydroxycyclohexanone + NADH
myo-inositol + NAD+
2,4,6/3,5-pentahydroxycyclohexanone + NADH + H+
-
i.e. scyllo-inosose
-
?
myo-inositol + NAD+
scyllo-inosose + NADH
-
-
-
r
myo-inositol + NAD+
scyllo-inosose + NADH + H+
-
-
-
?
[(4-methylphenyl)methyl]-myo-inositol + NAD+
? + NADH + H+
-
-
-
?
1-oxo-D-chiro-inositol + NADH + H+
D-chiro-inositol + NAD+
-
-
-
-
r
alpha-D-glucopyranose + NAD+
D-gluconate + NADH
-
4fold lower activity compared to myo-inositol as substrate, does not act with the beta-anomer
-
?
alpha-D-glucopyranosyl-(1,6)-myo-inositol + NAD+
?
-
-
-
-
?
D-glucose + NAD+
D-gluconate + NADH
-
-
-
?
D-xylose + NAD+
? + NADH
-
very low activity
-
?
myo-inositol + NAD+
2,4,6/3,5-pentahydroxycyclohexanone + NADH
-
-
-
?
myo-inositol + NAD+
scyllo-inosose + NADH
myo-inositol + NAD+
scyllo-inosose + NADH + H+
additional information
?
-
myo-inositol + NAD+
2,4,6/3,5-pentahydroxycyclohexanone + NADH
-
-
?
myo-inositol + NAD+
2,4,6/3,5-pentahydroxycyclohexanone + NADH
-
-
-
?
myo-inositol + NAD+
scyllo-inosose + NADH
-
first enzyme in the catabolic pathway of myo-inositol
-
-
r
myo-inositol + NAD+
scyllo-inosose + NADH
-
oxidation of the axial hydroxyl group of myo-inositol
-
-
r
myo-inositol + NAD+
scyllo-inosose + NADH + H+
-
-
-
-
?
myo-inositol + NAD+
scyllo-inosose + NADH + H+
-
-
-
-
r
myo-inositol + NAD+
scyllo-inosose + NADH + H+
-
the NAD+-dependent enzyme catalyses the oxidation of the axial hydroxyl group of myo-inositol to form scyllo-inosose
-
-
?
pinitol + NADH + H+
?
-
i.e. 3-O-methyl-D-chiro-inositol. Bacillus subtilis can utilize pinitol as the sole carbon source via the same myo-inositol catabolic pathway
-
-
?
pinitol + NADH + H+
?
-
i.e. 3-O-methyl-D-chiro-inositol
-
-
?
additional information
?
-
a nonpolar cavity adjacent to the active site, allows racemic protected inositol derivatives such as 4-O-benzyl-myo-inositol to be recognized with very high stereoselectivity. Trace activity with (1S,2S,3R,4S,5S)-2,3,4,5-tetrahydroxycyclohexyl dihydrogen phosphate
-
-
?
additional information
?
-
-
a nonpolar cavity adjacent to the active site, allows racemic protected inositol derivatives such as 4-O-benzyl-myo-inositol to be recognized with very high stereoselectivity. Trace activity with (1S,2S,3R,4S,5S)-2,3,4,5-tetrahydroxycyclohexyl dihydrogen phosphate
-
-
?
additional information
?
-
substrate specificity and substrate binding structure, molecular modeling, overview
-
-
?
additional information
?
-
-
substrate specificity and substrate binding structure, molecular modeling, overview
-
-
?
additional information
?
-
-
the enzyme shows a broad substrate spectrum while remaining highly stereoselective. BsIDH is able to oxidize the mono-saccharides alpha-D-glucose and alpha-D-xylose but not beta-D-glucose, D-mannose and D-galactose
-
-
?
additional information
?
-
-
scyllo-inositol is no substrate for the enzyme, thus IolG does not act as a scyllo-inositol dehydrogenase
-
-
?
additional information
?
-
-
structure-function analysis, overview
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
myo-inositol + NAD+
2,4,6/3,5-pentahydroxycyclohexanone + NADH
-
-
?
myo-inositol + NAD+
2,4,6/3,5-pentahydroxycyclohexanone + NADH + H+
-
i.e. scyllo-inosose
-
?
myo-inositol + NAD+
scyllo-inosose + NADH
-
-
-
r
1-oxo-D-chiro-inositol + NADH + H+
D-chiro-inositol + NAD+
-
-
-
-
r
myo-inositol + NAD+
2,4,6/3,5-pentahydroxycyclohexanone + NADH
-
-
-
?
myo-inositol + NAD+
scyllo-inosose + NADH
-
first enzyme in the catabolic pathway of myo-inositol
-
-
r
myo-inositol + NAD+
scyllo-inosose + NADH + H+
pinitol + NADH + H+
?
-
i.e. 3-O-methyl-D-chiro-inositol. Bacillus subtilis can utilize pinitol as the sole carbon source via the same myo-inositol catabolic pathway
-
-
?
additional information
?
-
-
the enzyme shows a broad substrate spectrum while remaining highly stereoselective. BsIDH is able to oxidize the mono-saccharides alpha-D-glucose and alpha-D-xylose but not beta-D-glucose, D-mannose and D-galactose
-
-
?
myo-inositol + NAD+
scyllo-inosose + NADH + H+
-
-
-
-
r
myo-inositol + NAD+
scyllo-inosose + NADH + H+
-
the NAD+-dependent enzyme catalyses the oxidation of the axial hydroxyl group of myo-inositol to form scyllo-inosose
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
7
(1S,2S,3R,4S,5S)-5-(allyloxy)cyclohexane-1,2,3,4-tetrol
25°C, pH 9.0
4
(1S,2S,3R,4S,5S)-5-(benzyloxy)cyclohexane-1,2,3,4-tetrol
25°C, pH 9.0
8
(1S,2S,3R,4S,5S)-5-methoxycyclohexane-1,2,3,4-tetrol
25°C, pH 9.0
44
4-([[(1S,2S,3R,4S,5S)-2,3,4,5-tetrahydroxycyclohexyl]oxy]methyl)benzoic acid
25°C, pH 9.0
57
melibiose
25°C, pH 9.0
3
methyl 4-([[(1S,2S,3R,4S,5S)-2,3,4,5-tetrahydroxycyclohexyl]oxy]methyl)benzoate
25°C, pH 9.0
9
alpha-D-glucopyranosyl-(1,6)-myo-inositol
-
-
4
myo-inositol
pH 9.0, 25°C, recombinant mutant Y233F
4.4
myo-inositol
pH 9.0, 25°C, recombinant wild-type enzyme
18
myo-inositol
25°C, pH 9.0
28
myo-inositol
pH 9.0, 25°C, recombinant mutant D179N
39
myo-inositol
pH 9.0, 25°C, recombinant mutant Y235F
65
myo-inositol
pH 9.0, 25°C, recombinant mutant D172N
118
myo-inositol
pH 9.0, 25°C, recombinant mutant H176A
0.07
NAD+
pH 9.0, 25°C, recombinant mutant Y233F
0.08
NAD+
pH 9.0, 25°C, recombinant wild-type enzyme
0.11
NAD+
pH 9.0, 25°C, recombinant mutant Y235F
0.3
NAD+
pH 9.0, 25°C, recombinant mutant H176A
0.4
NAD+
pH 9.0, 25°C, recombinant mutant D179N
1.1
NAD+
pH 9.0, 25°C, recombinant mutant D172N
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
?
-
x * 39170, His-tagged recombinant enzyme, SDS-PAGE
tetramer
-
4 * 39000, SDS-PAGE
tetramer
-
BsIDH is a tetramer, with an arrangement consisting of 2 long continuous beta-sheets, formed from all 4 monomers, in which the central 2 strands are crossed over to form the core of the tetramer. Each subunit in the tetramer consists of two domains, an N-terminal Rossmann fold domain containing the cofactor-binding site, and a C-terminal domain containing the inositol-binding site, structure-function analysis, overview
additional information
construction of an homology model of inositol dehydrogenase, to which NADH and 4-O-benzylscyllo-inosose are docked and the active site energy minimized, molecular modeling, overview
additional information
-
construction of an homology model of inositol dehydrogenase, to which NADH and 4-O-benzylscyllo-inosose are docked and the active site energy minimized, molecular modeling, overview
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
X-ray diffraction structure determination and analysis of enzyme mutant A12K/D35S/V36R complex with NADP+
purified recombinant His-tagged native and selenomethionine-labeled enzyme, 12 mg/ml wild-type protein in 25 mM Tris, pH 8.0, and 13.8 mg/ml of selenomethionine-labeled enzyme in 20 mM Tris, pH 8.0, and 5 mM DTT, 4°C, modified microbatch method, equal volumes of protein solution and precipitant solution of 0.001 ml, the latter containing 20%w/v PEG 3350, 0.20 M potassium fluoride, pH 8.5-9.0, are mixed, overlaid with a 1:1 mixture of silicone and paraffin oils, X-ray anomalous diffraction structure determination and analysis at 1.75-2.0 A resolution, molecular replacement
-
purified wild-type BsIDH and K97V mutant in apo-, holo- and ternary complexes with inositol and inosose, mixing of 0.002 ml of protein solution containing 10mg/ml protein in 25 mM Tris pH 8.0, with 0.002 ml reservoir solution containing 0.1-0.2 M tri-sodium citrate, pH 5.4, and 1.6-2.9 M ammonium sulfate, for the holo-enzyme complexes with 0.1 M tri-sodium citrate pH 5.4, 2.6 M ammonium sulfate and either inositol or inosose at 4 mg/0.1 ml mother liquid, cryoprotection with 25% ethylene glycol, X-ray diffraction structure determination and analysis at 2.3 A resolution
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
A12K/D35S/V36R
site-directed mutagenesis, the triple mutant has a value of 570000 M/s in reaction with NADP+, higher than that of the wild-type IDH with NAD+. The binding of the coenzyme in the mutant is altered such that although the nicotinamide ring maintains the required position for catalysis, the coenzyme has twisted by nearly 90°, so the adenine moiety no longer binds to a hydrophobic cleft in the Rossmann fold as in the wild-type enzyme
D172N
site-directed mutagenesis, the mutant shows highly reduced activity compared to the wild-type enzyme
D35S/V36R
site-directed mutagenesis, the double mutant prefers NADP+ to NAD+ by a factor of 5. The mutant is an excellent catalyst with a second-order rate constant with respect to NADP of 370000 M/s
H176A
site-directed mutagenesis, the mutant shows highly reduced activity compared to the wild-type enzyme
Y233F
site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type enzyme
Y233R
site-directed mutagenesis, inactive mutant
Y235F
site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type enzyme
Y235R
site-directed mutagenesis, inactive mutant
K97V
-
site-directed mutagenesis, inactive mutant
up
-
iolG expression is induced by myo-inositol, and less by scyllo-inositol
additional information
convertion of NAD+-specific inositol dehydrogenase to an efficient NADP+-selective catalyst to enhance understanding of coenzyme selectivity and to create an enzyme capable of recycling NADP+ in biocatalytic processes
additional information
-
convertion of NAD+-specific inositol dehydrogenase to an efficient NADP+-selective catalyst to enhance understanding of coenzyme selectivity and to create an enzyme capable of recycling NADP+ in biocatalytic processes
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Fujita, Y.; Shindo, K.; Miwa, Y.; Yoshida, K.
Bacillus subtiltis inositol dehydrogenase-encoding gene (idh): sequence and expression in Escherichia coli
Gene
108
121-125
1991
Bacillus subtilis (P26935), Bacillus subtilis
brenda
Ramaley, R.; Fujita, Y.; Freese, E.
Purification and properties of Bacillus subtilis inositol dehydrogenase
J. Biol. Chem.
254
7684-7690
1979
Bacillus subtilis
brenda
Daniellou, R.; Palmer, D.R.
Appel-Lee synthesis of glycosyl inositols, substrates for inositol dehydrogenase from Bacillus subtilis
Carbohydr. Res.
341
2145-2150
2006
Bacillus subtilis
brenda
Daniellou, R.; Phenix, C.P.; Tam, P.H.; Laliberte, M.C.; Palmer, D.R.
Stereoselective oxidation of protected inositol derivatives catalyzed by inositol dehydrogenase from Bacillus subtilis
Org. Biomol. Chem.
3
401-403
2005
Bacillus subtilis (P26935), Bacillus subtilis
brenda
Van Straaten, K.E.; Hoffort, A.; Palmer, D.R.; Sanders, D.A.
Purification, crystallization and preliminary X-ray analysis of inositol dehydrogenase (IDH) from Bacillus subtilis
Acta Crystallogr. Sect. F
64
98-101
2008
Bacillus subtilis
brenda
Daniellou, R.; Zheng, H.; Langill, D.M.; Sanders, D.A.; Palmer, D.R.
Probing the promiscuous active site of myo-inositol dehydrogenase using synthetic substrates, homology modeling, and active site modification
Biochemistry
46
7469-7477
2007
Bacillus subtilis (P26935), Bacillus subtilis
brenda
van Straaten, K.E.; Zheng, H.; Palmer, D.R.; Sanders, D.A.
Structural investigation of myo-inositol dehydrogenase from Bacillus subtilis: implications for catalytic mechanism and inositol dehydrogenase subfamily classification
Biochem. J.
432
237-247
2010
Bacillus subtilis
brenda
Morinaga, T.; Ashida, H.; Yoshida, K.
Identification of two scyllo-inositol dehydrogenases in Bacillus subtilis
Microbiology
156
1538-1546
2010
Bacillus subtilis, Bacillus subtilis 168
brenda
Zheng, H.; Bertwistle, D.; Sanders, D.A.; Palmer, D.R.
Converting NAD-specific inositol dehydrogenase to an efficient NADP-selective catalyst, with a surprising twist
Biochemistry
52
5876-5883
2013
Bacillus subtilis (P26935), Bacillus subtilis
brenda